You have probably heard of Ozempic, Wegovy, and other GLP-1 drugs. They have been all over the news for helping people manage their blood sugar and weight. Researchers are now exploring whether this same medication could help people struggling with alcohol and substance dependence and even problem gambling.

Ozempic (semaglutide) belongs to a class of medications called GLP-1 receptor agonists. These drugs work by mimicking a hormone in your body that affects appetite and blood sugar. But scientists noticed something unexpected: patients taking these medications were also reporting that they wanted to drink less. Some even said their urge to gamble or use other substances had quieted down.

That got scientist thinking, maybe this is about more than just food cravings.

Several studies found that taking semaglutides significantly reduced alcohol cravings, the amount people drank, and the number of heavy drinking days. Researchers now believe GLP-1 meds may work by changing how the brain’s reward system responds, basically making addictive behaviors feel less exciting. The sharp spike of dopamine that usually follows a drink or a gambling win doesn’t happen when you’re taking these medications.

It’s becoming more common to hear anecdotes like “Ozempic made me stop drinking,” and claims of “Losing desire for alcohol on Wegovy” and even “Why do I get disgusted by alcohol on Mounjaro.”

This research is still evolving, and semaglutide is not yet approved to treat addiction. But it’s a reminder that behavioral health and physical health are deeply connected, and that breakthroughs can come from unexpected places.

If you or someone you know is struggling with substance use or gambling, free support is available right here in Philadelphia. Call the DBHIDS helpline at 888-545-2600 or check our resources section for more information.

Learn more about Rethinking Alcohol Use Disorder Through GLP-1s.